Anti-epiligrin cicatricial pemphigoid clinical findings, immunopothogenesis, and significant associations

Medicine

Volumn 82, Issue 3, 2003, Pages 177-186

  Egan, Conleth A ^a   Lazarova, Zelmira ^b   Darling, Thomas N ^b   Yee, Carole ^b   Yancey, Kim B ^b  

^a BEAUMONT HOSPITAL   (Ireland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; EPILIGRIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOSUPPRESSIVE AGENT; KALININ; PROTEIN ANTIBODY; PROTEIN SUBUNIT; SODIUM CHLORIDE;

ADENOCARCINOMA; ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIGEN BINDING; ARTICLE; CANCER RISK; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; DISEASE COURSE; EXTRACELLULAR MATRIX; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOPATHOGENESIS; IMMUNOSUPPRESSIVE TREATMENT; MALE; MORTALITY; MUCOUS MEMBRANE PEMPHIGOID; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; REMISSION; RISK ASSESSMENT;

ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; BIOPSY; CELL ADHESION MOLECULES; COHORT STUDIES; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOBLOTTING; IMMUNOGLOBULIN G; IMMUNOHISTOCHEMISTRY; LAMININ; MALE; MIDDLE AGED; NEOPLASMS; PEMPHIGOID, BENIGN MUCOUS MEMBRANE; PRECIPITIN TESTS; SKIN;

EID: 0038247920     PISSN: 00257974     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005792-200305000-00004     Document Type: Article

References (59)

1. Ahmed AR, Maize JC, Provost TT. Bullous pemphigoid: Clinical and immunologic follow-up after successful therapy. Arch Dermatol 113: 1043-5, 1977.
2. Airio A, Pukkala E, Isomaki H. Elevated cancer incidence in patients with dermatomyositis: A population based study. J Rheumatol 22: 1300-3, 1995.
3. Bahadoran P, Perrin C, Aberdam D, Spadafora-Pisani A, Meneguzzi G, Ortonne JP. Altered expression of the hemidesmosome-anchoring filament complex proteins in basal cell carcinoma: Possible role in the origin of peritumoral lacunae. Br J Dermatol 136: 35-42, 1997.
4. Baker SE, Hopkinson SB, Fitchmun M, Andreason GL, Frasier F, Plopper G, Quaranta V, Jones JC. Laminin 5 and hemidesmosomes: Role of the α3 chain subunit in hemidesmosome stability and assembly. J Cell Sci 109: 2509-20, 1996.
5. Balding SD, Prost C, Diaz LA, Bernard P, Bedane C, Aberdam D, Giudice GJ. Cicatricial pemphigoid autoantibodies react with multiple sites on the BP180 extracellular domain. J Invest Dermatol 106: 141-6, 1996.
6. Basset-Seguin N, Caughman SW, Yancey KB. A-431 cells and human keratinocytes synthesize and secrete the third component of complement. J Invest Dermatol 95: 621-5, 1990.
7. Bean SF, Waisman M, Michel B, Thomas CI, Knox JM, Levine M. Cicatricial pemphigoid. Immunofluorescent studies. Arch Dermatol 106: 195-9, 1972.
8. Bedane C, McMillan JR, Balding SD, Bernard P, Prost C, Bonnetblanc JM, Diaz LA, Eady RA, Giudice GJ. Bullous pemphigoid and cicatricial pemphigoid autoantibodies react with ultrastructurally separable epitopes on the BP180 ectodomain: Evidence that BP180 spans the lamina lucida. J Invest Dermatol 108: 901-7, 1997.
9. Bernard P, Prost C, Durepaire N, Basset-Seguin N, Didierjean L, Seurat JH. The major cicatricial pemphigoid antigen is a 180-kD protein that shows immunologic cross-reactivities with the bullous pemphigoid antigen. J Invest Dermatol 99: 174-9, 1992.
10. Bernard P, Vaillant L, Labeille B, Bedane C, Arbeille B, Denoeux JP, Lorette G, Bonnetblanc JM, Prost C. Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Bullous Diseases French Study Group. Arch Dermatol 131: 48-52, 1995.
11. Boudreau N, Bissell MJ. Extracellular matrix signaling: Integration of form and function in normal and malignant cells. Curr Opin Cell Biol 10: 640-6, 1998.
12. Chan LS, Ahmed AR, Anhalt GJ, Bernauer W, Cooper KD, Elder MJ, Fine JD, Foster CS, Ghohestani R, Hashimoto T, Hoang-Xuan T, Kirtschig G, Korman NJ, Lightman S, Lozada-Nur F, Marinkovich MP, Mondino BJ, Prost-Squarcioni C, Rogers RS III, Setterfield JF, West DP, Wojnarowska F, Woodley DT, Yancey KB, Zillikens D, Zone JJ. The first international consensus on mucous membrane pemphigoid: Definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators. Arch Dermatol 138: 370-9, 2002.
13. Chopra A, Maitra B, Korman NJ. Decreased mRNA expression of several basement membrane components in basal cell carcinoma. J Invest Dermatol 110: 52-6, 1998.
14. Chorzelski TP, Jablonska S, Maciejowska E, Beutner EH, Wronkowski L. Coexistence of malignancies with bullous pemphigoid. Arch Dermatol 114: 964, 1978.
15. Domloge-Hultsch N, Anhalt GJ, Gammon WR, Lazarova Z, Briggaman R, Welch M, Jabs DA, Huff C, Yancey KB. Anti-epiligrin cicatricial pemphigoid. A subepithelial bullous disorder. Arch Dermatol 130: 1521-9, 1994.
16. Domloge-Hultsch N, Gammon W, Briggaman R, Gil S, Carter W, Yancey K. Epiligrin, the major human keratinocyte integrin ligand, is a target in both an acquired autoimmune and an inherited subepidermal blistering skin disease. J Clin Invest 90: 1628-33, 1992.
17. Egan CA, Lazarova Z, Darling TN, Yee C, Cote T, Yancey KB. Antiepiligrin cicatricial pemphigoid and relative risk for cancer. Lancet 357: 1850-1, 2001.
18. Egan CA, Yancey KB. The clinical and immunopathological manifestations of anti-epiligrin cicatricial pemphigoid. Eur J Dermatol 10: 585-9, 2000.
19. Fujimoto W, Ishida-Yamamoto A, Hsu R, Nagao Y, Iizuka H, Yancey KB, Arata J. Anti-epiligrin cicatricial pemphigoid: A case associated with gastric carcinoma and features resembling epidermolysis bullosa acquisita. Br J Dermatol 139: 682-7, 1998.
20. Fujimoto W, Toi Y, Okazaki F, Lazarova Z, Yancey KB, Arata J. Anti-epiligrin cicatricial pemphigoid with IgG autoantibodies to the β and γ subunits of laminin 5. J Am Acad Dermatol 40: 637-9, 1999.
21. Ghohestani RF, Nicolas JF, Rousselle P, Claudy AL. Identification of a 168 kD mucosal antigen in a subset of patients with cicatricial pemphigoid. J Invest Dermatol 107: 136-9, 1996.
22. Giannelli G, Falk-Marzillier J, Schiraldi O, Stetler-Stevenson WG, Quaranta V. Induction of cell migration by matrix metalloprotease 2 cleavage of laminin 5. Science 277: 225-8, 1997.
23. Goldfinger LE, Stack MS, Jones JCR. Processing of laminin 5 and its functional consequences: Role of plasmin and tissue-type plasminogen activator. J Cell Biol 141: 255-65, 1998.
24. Hao J, Yang Y, McDaniel KM, Dalkin BL, Cress AE, Nagle RB. Differential expression of laminin 5 (α3β3γ2) by human malignant and normal prostate. Am J Pathol 149: 1341-9, 1996.
25. Hashimoto T, Murakami H, Senboshi Y, Kanzaki H, Arata J, Yancey KB, Nishikawa T. Anti-epiligrin cicatricial pemphigoid: The first case report from Japan. J Am Acad Dermatol 34: 940-2, 1996.
26. 4 autoantibodies predominate in patients with anti-epiligrin cicatricial pemphigoid. J Invest Dermatol 109: 557-61, 1997.
27. Kawahara Y, Amagai M, Ohata Y, Ishii K, Hasegawa Y, Hsu R, Yee C, Yancey KB, Nishikawa T. A case of cicatricial pemphigoid with simultaneous IgG autoantibodies against the 180 kD bullous pemphigoid antigen and laminin 5. J Am Acad Dermatol 38: 624-7, 1998.
28. Kirtschig G, Marinkovich MP, Burgeson RE, Yancey KB. Antibasement membrane autoantibodies in patients with anti-epiligrin cicatricial pemphigoid bind the alpha subunit of laminin 5. J Invest Dermatol 105: 543-8, 1995.
29. Lazarova Z, Domloge-Hultsch N, Yancey KB. Epiligrin is decreased in papulonodular basal cell carcinoma tumor nest basement membranes and the extracellular matrix of transformed human epithelial cells. Exp Dermatol 4: 121-9, 1995.
30. Lazarova Z, Hsu R, Briggaman RA, Yancey KB. Fab fragments directed against laminin 5 induce subepidermal blisters in neonatal mice. Clin Immunol 95: 26-32, 2000.
31. Lazarova Z, Hsu R, Yee C, Yancey KB. Anti-epiligrin cicatricial pemphigoid represents an autoimmune response to subunits present in laminin 5 (α3β3γ2). Br J Dermatol 139: 791-7, 1998.
32. Lazarova Z, Hsu R, Yee C, Yancey KB. Human anti-laminin 5 autoantibodies induce subepidermal blisters in an experimental skin graft model. J Invest Dermatol 114: 178-84, 2000.
33. Lazarova Z, Yancey KB. Reactivity of autoantibodies from patients with defined subepidermal bullous diseases against 1 mol/L NaCl-split skin. J Am Acad Dermatol 35: 398-403, 1996.
34. Lazarova Z, Yee C, Darling T, Briggaman RA, Yancey KB. Passive transfer of anti-laminin 5 antibodies induces subepidermal blisters in neonatal mice. J Clin Invest 98: 1509-18, 1996.
35. Lazarova Z, Yee C, Lazar J, Yancey KB. IgG autoantibodies in patients with anti-epiligrin cicatricial pemphigoid recognize the G domain of the laminin 5 alpha-subunit. Clin Immunol 101: 100-5, 2001.
36. Lenz P, Hsu R, Yee C, Yancey K, Volc-Platzer B, Stingl G, Kirnbauer R. Vernarbendes pemphigoid mit autoantikorpern gegen laminin 5 (epiligrin) bei einer patientin mit metastasierendem endometriumkarzinom. Der Hautarzt 49: 31-5, 1998.
37. Lever W. Pemphigus. Medicine (Baltimore) 32: 1-123, 1953.
38. Leverkus M, Schmidt E, Lazarova Z, Brocker EV, Yancey KB, Zillikens D. Anti-epiligrin cicatricial pemphigoid: An underdiagnosed entity within the spectrum of scarring autoimmune subepidermal bullous diseases? Arch Dermatol 135: 1091-8, 1999.
39. Lish KM, Washenik K, Yancey KB, Yee C, Rico MJ. Anti-epiligrin cicatricial pemphigoid in a patient with HIV. J Am Acad Dermatol 36: 486-8, 1997.
40. Martin KJ, Kwan CP, Nagasaki K, Zhang X, O'Hare MJ, Kaelin CM, Burgeson RE, Pardee AB, Sager R. Down regulation of laminin 5 in breast carcinoma cells. Mol Med 4: 602-13, 1998.
41. Miyazaki, Kikkawa Y, Nakamura A, Yasumitsu H, Umeda M. A large cell-adhesive scatter factor secreted by human gastric carcinoma cells. Proc Natl Acad Sci U S A 90: 11767-71, 1993.
42. Mizushima H, Miyagi Y, Kikkawa Y, Yamanaka N, Yasumitsu H, Misugi K, Miyazaki K. Differential expression of laminin 5/ladsin subunits in human tissues and cancer cell lines and their induction by tumor promoter and growth factors. J Biochem (Tokyo) 120: 1196-202, 1996.
43. Nousari HC, Rencic A, Hsu R, Yancey KB, Anhalt GJ. Anti-epiligrin cicatricial pemphigoid with antibodies against the γ2 subunit of laminin 5. Arch Dermatol 135: 173-6, 1999.
44. Person J, Rogers R. Bullous and cicatricial pemphigoid: Histopathologic and immunopathologic correlations. Mayo Clin Proc 52: 54-66, 1977.
45. Ryan MC, Tizard R, VanDevanter DR, Carter WG. Cloning of the LAMA3 gene encoding the α3 chain of the adhesive ligand epiligrin. J Biol Chem 269: 22779-87, 1994.
46. Savin JA. The events leading to death of patients with pemphigus and pemphigoid. Br J Dermatol 101: 521-34, 1979.
47. Schroeter AL. Pemphigoid and malignancy. Clin Dermatol 5: 60-3, 1987.
48. Setterfield J, Shirlaw Pj, Lazarova Z, Tilling K, Challacombe SJ, Black MM. Paraneoplastic cicatricial pemphigoid. Br J Dermatol 141: 127-31, 1999.
49. Sigurgeirsson B, Lindelof B, Edhag O, Allander E. Risk of cancer in patients with dermatomyositis or polymyositis: A population based study. N Engl J Med 326: 363-7, 1992.
50. Smith EP, Taylor TB, Meyer LJ, Zone JJ. Identification of a basement membrane zone antigen reactive with circulating IgA antibody in ocular cicatricial pemphigoid. J Invest Dermatol 101: 619-23, 1993.
51. Smith EP, Zone JJ, Egan CA, Taylor TB, Meyer LJ, Petersen MJ. The 45-kD ocular cicatricial pemphigoid antigen is a keratin [abstract]. J Invest Dermatol 110: 509, 1998.
52. Stone SP, Schroeter AL. Bullous pemphigoid and associated malignant neoplasms. Arch Dermatol 111: 991-4, 1975.
53. Taniuchi K, Takata M, Matsui C, Fushida Y, Uchiyama K, Mori T, Kawara S, Yancey KB, Takehara K. Anti-epiligrin cicatricial pemphigoid associated with an underlying gastric carcinoma producing laminin 5. Br J Dermatol 140: 696-700, 1999.
54. Timpl R. Macromolecular organization of basement membranes. Curr Opin Cell Biol 8: 618-24, 1996.
55. Tyagi S, Bhol K, Natarajan K, Livir-Rallatos C, Foster CS, Ahmed AR. Ocular cicatricial pemphigoid antigen: Partial sequence and biochemical characterization. Proc Natl Acad Sci U S A 93: 14714-9, 1996.
56. Uchiyama K, Yamamoto Y, Taniuchi K, Matsui C, Fushida Y, Shirao Y. Remission of anti-epiligrin (laminin-5) cicatricial pemphigoid after excision of gastric carcinoma. Cornea 19: 564-6, 2000.
57. Yancey KB, Kirtschig G, Yee C, Lazarova Z. Studies of patients with anti-epiligrin cicatricial pemphigoid. J Dermatol 22: 829-35, 1995.
58. Yancey K. Cicatricial pemphigoid. In: Freedberg I, Eisen A, Wolff K, Austen K, Goldsmith L, Katz SI, et al, eds. Dermatology in general medicine, 5th ed. New York: McGraw-Hill, pp 674-9, 1999.
59. Zillikens D, Wever S, Roth A, Hashimoto T, Brocker E. Incidence of autoimmune subepidermal blistering dermatoses in a region of central Germany. Arch Dermatol 131: 957-8, 1995.